Can-Fite BioPharma Ltd. (CANF) › Capital ExpendituresCan-Fite BioPharma Ltd. (CANF) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $7.0K2018: $33.0K2019: $3.0K2020: $26.0K2021: $11.0K2022: $9.0K2023: $2.0K2024: $5.0K2025: $2.0K$2.0K2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$2.0K-60.0%2024$5.0K+150.0%2023$2.0K-77.8%2022$9.0K-18.2%2021$11.0K-57.7%2020$26.0K+766.7%2019$3.0K-90.9%2018$33.0K+371.4%2017$7.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share